Clinical Trial Update: Comparison of Drug Eluting and Bare Metal Stents With or Without Abciximab in ST Elevation Myocardial Infarction [Phase 4]

View source ↗

Summary

Phase 4 trial comparing drug-eluting versus bare metal stents in acute myocardial infarction, with or without Abciximab, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Abciximab (abciximab)

Snippet

Sponsor: Catharina Ziekenhuis Eindhoven | Conditions: Acute Myocardial Infarction | Phase 4 | Status: COMPLETED